» Articles » PMID: 17610374

Age-related Changes in the Frequency of Mesenchymal Stem Cells in the Bone Marrow of Rats

Overview
Journal Stem Cells Dev
Date 2007 Jul 6
PMID 17610374
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are pluripotent cells that can differentiate into endothelial, osteogenic, adipogenic, and other lineages. In spite of the broad interest, little is known about the variation of MSC number in relation to the age of the donor. The aim of this study was to investigate the age-associated variations of bone marrow (BM) MSCs using a rat model. Cell populations were characterized by flow cytometry using light-scattering parameters, DNA content and a set of monoclonal antibodies and detected by magnetic resonance imaging (MRI). Single-cell analysis was performed by conventional fluorescent microscopy. BM mononucleated cells (MNCs) were isolated, in vitro culture of MSCs was established, and endothelial cells differentiation and intracellular magnetic labeling was shown. The amount of BM tissue obtainable from femurs and tibiae increased with age and reached a maximum in 8- to 12-week-old rats. At the same time, the proportional number of MNCs containing MSCs decreased. As a result, after 2 weeks of culture, the maximum yield of MSC number was registered from the youngest age group (4 weeks). MSCs were differentiated into endothelial cells by administration of vascular endothelial growth factor (VEGF) and subsequently revealed immunocytochemical and morphological characteristics of endothelial cells. The results of our study are the basis for further experiments with MSCs and their endothelial descendants, which may be labeled with different agents for cell tracking and detection experiments, but age-related changes in MSCs number should be taken into account whenever these cells are considered for practical applications.

Citing Articles

The potency of mesenchymal stem/stromal cells: does donor sex matter?.

Maged G, Abdelsamed M, Wang H, Lotfy A Stem Cell Res Ther. 2024; 15(1):112.

PMID: 38644508 PMC: 11034072. DOI: 10.1186/s13287-024-03722-3.


Mesenchymal Stromal Cells Derived from Dental Tissues: Immunomodulatory Properties and Clinical Potential.

Poblano-Perez L, Castro-Manrreza M, Gonzalez-Alva P, Fajardo-Orduna G, Montesinos J Int J Mol Sci. 2024; 25(4).

PMID: 38396665 PMC: 10888494. DOI: 10.3390/ijms25041986.


BHLHE40 Maintains the Stemness of PαS Cells In Vitro by Targeting through the Wnt/β-Catenin Signaling Pathway.

Hu M, Tian Y, Liu X, Guo Q, Lu D, Wang X Biomedicines. 2023; 11(8).

PMID: 37626688 PMC: 10452820. DOI: 10.3390/biomedicines11082190.


Repurpose dasatinib and quercetin: Targeting senescent cells ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration.

Wang Y, Che L, Chen X, He Z, Song D, Yuan Y Bioact Mater. 2023; 25:13-28.

PMID: 37056256 PMC: 10088057. DOI: 10.1016/j.bioactmat.2023.01.009.


Adult mesenchymal stem cells: is there a role for purine receptors in their osteogenic differentiation?.

Carluccio M, Ziberi S, Zuccarini M, Giuliani P, Caciagli F, Di Iorio P Purinergic Signal. 2020; 16(3):263-287.

PMID: 32500422 PMC: 7524949. DOI: 10.1007/s11302-020-09703-4.